Hypothalamic Amenorrhea Clinical Trial
Official title:
Hypothalamic Amenorrhea as a Fertility Status Marker for Cardiovascular Health
Hypothalamic amenorrhea (HA) occurs during reproductive years and results in stopped menstrual cycles and infertility which can be prolonged from months to years and is characterized by varying combinations of psychosocial stress, anxiety, high levels of physical activity, and/or weight loss. Data from our group indicates that one-third of women with HA (mean age: 27 yrs) have preclinical cardiovascular disease (CVD) measured noninvasively as vascular dysfunction and vascular inflammation. This study will use HA as a marker of fertility status for cardiovascular health and perform dense-phenotyping using remote patient monitoring (FitBit) and patient reported outcomes (questionnaires) to determine which HA phenotypes are related to preclinical CVD and inflammation.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02984696 -
Total Antioxidant Capacity Before and After HRT in Hypotalamic Amenorrhea
|
N/A | |
Recruiting |
NCT01601171 -
Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate
|
||
Completed |
NCT00556036 -
Hormone Dynamics and Bone Mineral Density in Anorexia Nervosa v. Hypothalamic Amenorrhea
|
||
Terminated |
NCT01165619 -
Detailed Clinical, Biochemical and Genetic Characterization in Gonadotropin-releasing Hormone (GnRH) Deficiency Disorders
|
N/A | |
Recruiting |
NCT03841981 -
Body Fat as Determinant of Female Gonadal Dysfunction
|
||
Completed |
NCT03018366 -
Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women
|
Phase 2 | |
Recruiting |
NCT05633966 -
Kisspeptin Administration Subcutaneously to Patients With Reproductive Disorders
|
Phase 1 | |
Terminated |
NCT00889512 -
The Luveris In Vitro Fertilization Trial
|
Phase 4 |